Trials / Completed
CompletedNCT03535233
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Combined Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Alopecia areata (AA) presents with circumscribed patches of non-scarring hair loss. It inflects a significant psychological and social burden. Many treatment options are used for the treatment of AA. Randomized controlled trials comparing intralesional and topical therapy and comparing combinations are few. The aim of this work is to evaluate the efficacy of combined topical 5% minoxidil and potent topical corticosteroid therapy compared to intralesional triamcinolone injection in alopecia areata
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone Acetonide | |
| DRUG | Minoxidil 5 % Topical Spray | |
| DRUG | clobetasol propionate |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Completion
- 2017-09-01
- First posted
- 2018-05-24
- Last updated
- 2018-05-24
Source: ClinicalTrials.gov record NCT03535233. Inclusion in this directory is not an endorsement.